Vertex Pharmaceuticals Incorporated (VRTX) Balance Sheet
As of 2026-06-30 (10-Q), Vertex Pharmaceuticals Incorporated (VRTX) reported total assets of $27.4B, total liabilities of $7.2B and shareholders' equity of $20.2B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.1B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VRTXVertex Pharmaceuticals IncorporatedFollow VRTX — free
—
Price chart with a free account
- Market cap
- 132.8B
- P/E TTM
- 30.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Jan 18 | FY2018 Jan 19 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.24 | 0.48 | 0.49 | 0.57 | 0.63 | 0.71 | 1.18 | — | — | 3.11 | 5.99 | 6.80 | 10.50 | 10.37 | 4.57 | 5.08 | 6.14 | |
| Short-term investments | 0.79 | 0.49 | 0.83 | 0.90 | 0.76 | 0.33 | 0.25 | 0.42 | 0.52 | 0.70 | 0.67 | 0.73 | 0.27 | 0.85 | 1.55 | 1.52 | 1.71 | |
| Receivables | 0.01 | 0.18 | 0.14 | 0.09 | 0.08 | 0.17 | 0.20 | 0.31 | 0.41 | 0.63 | 0.89 | 1.14 | 1.44 | 1.56 | 1.61 | 2.05 | 2.13 | |
| Inventory | — | 0.11 | 0.03 | 0.01 | 0.03 | 0.06 | 0.08 | 0.11 | 0.12 | 0.17 | 0.28 | 0.35 | 0.46 | 0.74 | 1.21 | 1.69 | 1.77 | |
| Current assets | 1.06 | 1.33 | 1.59 | 1.59 | 1.55 | 1.41 | 1.83 | 2.65 | 3.84 | 4.82 | 8.13 | 9.56 | 13.23 | 14.14 | 9.60 | 11.20 | 12.54 | |
| Total assets | 1.73 | 2.20 | 2.76 | 2.32 | 2.33 | 2.50 | 2.90 | 3.56 | 6.26 | 8.32 | 11.75 | 13.43 | 18.15 | 22.73 | 22.53 | 25.64 | 27.42 | |
| Current liabilities | 0.47 | 0.39 | 0.43 | 0.40 | 0.37 | 0.51 | 0.79 | 0.81 | 1.12 | 1.33 | 1.88 | 2.14 | 2.74 | 3.55 | 3.56 | 3.86 | 3.94 | |
| Long-term debt | 0.12 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Short-term debt | — | — | — | — | 0.01 | 0.07 | 0.00 | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 1.22 | 1.24 | 1.52 | 0.96 | 1.24 | 1.40 | 1.56 | 1.50 | 1.81 | 2.23 | 3.07 | 3.33 | 4.24 | 5.15 | 6.12 | 6.98 | 7.18 | |
| Shareholders' equity | 0.50 | 0.79 | 1.00 | 1.36 | 1.08 | 0.94 | 1.16 | 2.03 | — | 6.09 | 8.69 | 10.10 | 13.91 | 17.58 | 16.41 | 18.67 | 20.25 |
USD billions · SEC XBRL
Vertex Pharmaceuticals Incorporated — questions
- How much cash does Vertex Pharmaceuticals Incorporated have?
- $6.1B in cash and cash equivalents as of 2026-06-30.
- What are Vertex Pharmaceuticals Incorporated's total assets?
- $27.4B as of 2026-06-30.
- What is Vertex Pharmaceuticals Incorporated's shareholders' equity?
- $20.2B as of 2026-06-30.
Every figure on this page comes from Vertex Pharmaceuticals Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.